The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
03/01/2013
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
RFA-AR-14-005
Opportunity Category:
Discretionary
Posted Date:
Mar 01, 2013
Creation Date:
Mar 01, 2013
Original Closing Date for Applications:
Aug 01, 2013
Current Closing Date for Applications:
Aug 01, 2013
Archive Date:
Sep 01, 2013
Funding Instrument Type:
Grant
Category of Funding Activity:
Health
Category Explanation:
Expected Number of Awards:
Estimated Total Program Funding:
$1,000,000
Award Ceiling:
$225,000
Award Floor:
CFDA Number(s):
93.846
--
Arthritis, Musculoskeletal and Skin Diseases Research
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Small businesses
Additional Information on Eligibility:
Agency Name
National Institutes of Health
Description
This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose preclinical studies to advance the development of biomarkers or treatments for rare musculoskeletal, rheumatic or skin diseases. Rare diseases have a prevalence of fewer than 200,000 affected individuals in the United States. Also eligible for potential funding through this initiative are studies of FDA-designated orphan products for musculoskeletal, rheumatic or skin diseases.
